Insights

Expanding Global Partnerships BioNTech actively collaborates with international organizations such as Global Health EDCTP3 and NHS England, indicating a strong openness to strategic partnerships in healthcare research and clinical trials. This presents opportunities to offer advanced biotech solutions, trial support services, or joint research initiatives.

Focused Oncology Initiatives With recent launches of a Clinical Trial Oncology Platform and strategic collaborations in cancer research, BioNTech is positioning itself as a key player in immunotherapy and personalized cancer treatments. Companies offering trial management, biosimilar development, or oncology-specific technology solutions could find relevant business opportunities.

Innovation in mRNA Technologies Having over a decade of fundamental research and a highly experienced team in mRNA technology, BioNTech is a prime target for innovative biotech providers specializing in mRNA delivery systems, vaccine development, and related biotech innovations that can boost their pipeline or research capabilities.

Strategic Cost Management The recent reduction in headcount suggests a focus on strategic realignment and cost optimization. This opens opportunities to support BioNTech with operational efficiency solutions, HR technology, or consulting services aimed at streamlining biotech operations.

Growth Through International Markets BioNTech's activities in Africa and partnerships in Europe demonstrate a strategic focus on expanding access to immunotherapies and vaccines globally. This expanding market presence offers potential sales avenues for global supply chain providers, distribution partners, or localized biotech solutions tailored for emerging markets.

BioNTech SE Tech Stack

BioNTech SE uses 8 technology products and services including SAS, LottieFiles, ADP, and more. Explore BioNTech SE's tech stack below.

  • SAS
    Business Intelligence
  • LottieFiles
    Design
  • ADP
    Human Resource Management System
  • Slider Revolution
    Miscellaneous
  • LinkedIn
    Online Community Software
  • Akamai mPulse
    Real User Monitoring
  • Google
    Search Engines
  • Apache
    Web Servers

Media & News

BioNTech SE's Email Address Formats

BioNTech SE uses at least 2 format(s):
BioNTech SE Email FormatsExamplePercentage
First.Last@biontech.deJohn.Doe@biontech.de
88%
FLast@biontech.deJDoe@biontech.de
5%
LF@biontech.deDJ@biontech.de
2%
First.Middle@biontech.deJohn.Michael@biontech.de
2%
Last.First@biontech.deDoe.John@biontech.de
1%
First.L@biontech.deJohn.D@biontech.de
1%
First.MiddleLast@biontech.deJohn.MichaelDoe@biontech.de
1%
First.Last@biontech.comJohn.Doe@biontech.com
74%
FLast@biontech.comJDoe@biontech.com
23%
First@biontech.comJohn@biontech.com
3%

Frequently Asked Questions

Where is BioNTech SE's headquarters located?

Minus sign iconPlus sign icon
BioNTech SE's main headquarters is located at An der Goldgrube 12 Mainz, Rhineland-Palatinate 55131 DE. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is BioNTech SE's phone number?

Minus sign iconPlus sign icon
You can contact BioNTech SE's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BioNTech SE's stock symbol?

Minus sign iconPlus sign icon
BioNTech SE is a publicly traded company; the company's stock symbol is BNTX.

What is BioNTech SE's official website and social media links?

Minus sign iconPlus sign icon
BioNTech SE's official website is biontech.com and has social profiles on LinkedIn.

How much revenue does BioNTech SE generate?

Minus sign iconPlus sign icon
As of September 2025, BioNTech SE's annual revenue reached $750M.

What is BioNTech SE's SIC code NAICS code?

Minus sign iconPlus sign icon
BioNTech SE's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BioNTech SE have currently?

Minus sign iconPlus sign icon
As of September 2025, BioNTech SE has approximately 5K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer & Co-Founder: U. S.Chief Financial Officer: R. Z.Chief Of Staff To Cco: M. P.. Explore BioNTech SE's employee directory with LeadIQ.

What industry does BioNTech SE belong to?

Minus sign iconPlus sign icon
BioNTech SE operates in the Biotechnology Research industry.

What technology does BioNTech SE use?

Minus sign iconPlus sign icon
BioNTech SE's tech stack includes SASLottieFilesADPSlider RevolutionLinkedInAkamai mPulseGoogleApache.

What is BioNTech SE's email format?

Minus sign iconPlus sign icon
BioNTech SE's email format typically follows the pattern of . Find more BioNTech SE email formats with LeadIQ.

How much funding has BioNTech SE raised to date?

Minus sign iconPlus sign icon
As of September 2025, BioNTech SE has raised $145M in funding. The last funding round occurred on May 29, 2024 for $145M.

When was BioNTech SE founded?

Minus sign iconPlus sign icon
BioNTech SE was founded in 2008.
BioNTech SE

BioNTech SE

Biotechnology ResearchRhineland-Palatinate, Germany5001-10000 Employees

Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases. 

BioNTech is headquartered in Mainz, Germany, and operates globally with almost 7.000 pioneers. Our work is powered by one mission: Improving the health of people worldwide. We believe that scientific rigor and passion are the driving forces that are essential for innovative progress.  

BioNTech was founded in 2008 by scientists and physicians to translate science into survival by combining fundamental research and operational excellence. At BioNTech, we have been conducting fundamental research of mRNA technologies in the field of individualized cancer medicine for more than a decade. Some of our colleagues, including our co-founders, have been researching and developing mRNA-based vaccines for more than 25 years. 

Ready to join us on this journey? Explore the opportunities and become part of a team that aspires to turn bold ideas into real-world solutions: www.biontech.com/careers 

🔗 Privacy Statement: https://www.biontech.com/int/en/home/data-privacy-statement.html  
 
🔗 Imprint: https://www.biontech.com/int/en/home/imprint.html

Section iconCompany Overview

Headquarters
An der Goldgrube 12 Mainz, Rhineland-Palatinate 55131 DE
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
BNTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
5001-10000

Section iconFunding & Financials

  • $145M

    BioNTech SE has raised a total of $145M of funding over 10 rounds. Their latest funding round was raised on May 29, 2024 in the amount of $145M.

  • $100M$1B

    BioNTech SE's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $145M

    BioNTech SE has raised a total of $145M of funding over 10 rounds. Their latest funding round was raised on May 29, 2024 in the amount of $145M.

  • $100M$1B

    BioNTech SE's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.